Common name
|
B-Luc-EGFP HL-60
|
Catalog number
|
321821
|
Aliases
|
NA
|
Disease
|
Acute myelogenous leukemia
|
Organism
|
Human
|
Strain
|
NA
|
Tissue types
|
Peripheral blood
|
Tissue
|
Peripheral blood
|
Description
This B-Luc-EGFP HL-60 cell line expresses firefly luciferase as a marker of HL-60 cells. Fluorescence could be detected in B-Luc-EGFP HL-60 cells.
Application
B-Luc-EGFP HL-60 cell line can be used to evaluate anti-cancer drugs in acute myelogenous leukemia in vivo.
Targeting strategy
Gene targeting strategy for B-Luc-EGFP HL-60 cells. The CMV promoter and luciferase-EGFP were inserted into the targeting vector used in the lentivirus system.
In vitro luciferase activity of B-Luc-EGFP HL-60 cells
Luminescence signal intensity of B-Luc-EGFP HL-60 cells. Luminescence intensity was measured using the Bright-GloTM luciferase Assay (Promega, Cat E2610). B-Luc-EGFP HL-60 cells have a strong luminescence signal. EGFP was detected in B-Luc-EGFP HL-60 cells. The 1-B06 clone of B-Luc-EGFP HL-60 cells can be used in vivo experiments.
Quantitative imaging data & body weight changes
B-Luc-EGFP HL-60 cells (1x105) were injected into the tail vein of wild-type B-NDG mice. Signal intensity and body weight were measured twice a week. (A) Imaging was performed twice a week. (B) Body weight (Mean ± SEM). B-Luc-EGFP HL-60 cells can be used for in vivo efficacy evaluation.